Life science current events reported by MedCity News this week.
Why are some doctors and nurses giving back their iPads? So why do some healthcare workers like tablets and others don’t? It’s all about the data entry, said Larson, who spoke this week at the Healthcare Information Transformation conference in Jacksonville, Florida. Jobs that require lots of typing don’t work well for the iPad. Meanwhile, if a healthcare worker is largely reading “static” content, then tablet computing works for them.
What venture capitalists look for in personalized medicine investments. Companies like Starbucks (NASDAQ:SBUX), Amazon.com (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) aren’t healthcare companies, but one venture capitalist believes their example can guide personalized medicine. Bob Kocher, a partner at venture capital firm Venrock, said that these consumer-focused companies have all taken steps toward personalizing their offerings. Personalization increases the value of those offerings and helps the companies make delivery of services and products more efficient.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Athersys CEO: Stroke therapy could be one of the biggest blockbusters ever. He also shared some eye-popping numbers: “Even if you make some pretty modest assumptions about what the therapy would be priced at, then that leads you pretty quickly to a picture or a scenario where you could see that this market opportunity could be $15 billion to $20 billion a year easily.”
Tie to Mayo Clinic prompts software company down the medical device path. A road less traveled may bring riches. At least that is the hope at Preventice, a Minneapolis software company whose association with Mayo Clinic is leading it to foray into the world of medical devices. The company – formerly called Boost Information Systems and based near Mayo in Rochester – is building a miniature, remote body monitor called BodyGuardian.
Biomet offers $280M to acquire DePuy Orthopaedics’ trauma business. “This transaction will provide Biomet with a much stronger presence in the global trauma market and greatly expands our sports, extremities and trauma business, which is a meaningful growth driver for Biomet,” said President and CEO Jeffrey R. Binder in a statement
